“Mannatech is celebrating its 20 th year. I’ve had the privilege of being a part of this company for seven of those years,” explains Al Bala, President. “I’ve never been more excited about how the company is poised than I am right now. The value we provide to the market while still offering nutritional products of the highest integrity and efficacy is simply unprecedented. Our global footprint and seamless compensation plan position us for international strength. And our unique technology places us in two categories that are key for the future: wellness and anti-aging. These are very exciting times for Mannatech, and I’m anxious to help our independent Associates capitalize on what lies ahead.”“Mannatech continues to experience a fundamental shift in our global business,” explains Dr. Robert Sinnott, CEO and Chief Science Officer. “Over the last few years we have seen business outside North America become a larger share of our global business. This is a healthy shift that is necessary to become a diverse global community. Mr. Al Bala has been a very innovative force for Mannatech over the last several years. His global experiences and strong working relationships with our general managers and global sales force will help foster this global shift.” For the first quarter 2014, Mannatech reported that operations outside of North America accounted for approximately 52.8% of consolidated net sales (compared to 50.8% for first quarter 2013). During this same timeframe, Asia/Pacific net sales increased by 6.7%, and EMEAA net sales increased by 8.8%. Individuals interested in Mannatech’s products or exploring its business opportunity are encouraged to learn more at Mannatech.com. About Mannatech Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, United Kingdom, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico, Hong Kong and Namibia. For more information, visit Mannatech.com. Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.